Novartis AG (NVS)
24 Sep 2018
* SANDOZ RECEIVES POSITIVE CHMP OPINION FOR PROPOSED BIOSIMILAR PEGFILGRASTIM
* ANNOUNCES POSITIVE CHMP OPINION FOR ONE-TIME GENE THERAPY LUXTURNA® TO TREAT CHILDREN AND ADULTS WITH RARE INHERITED RETINAL DISEASE Source text for Eikon: Further company coverage:
* NOVARTIS RECEIVES POSITIVE CHMP OPINION FOR GILENYA® FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH MS, MARKING A MAJOR MEDICAL ADVANCE FOR YOUNG MS PATIENTS IN EUROPE Source text for Eikon: Further company coverage:
ZURICH, Sept 21 A European Medicines Agency panel recommended approval of Spark Therapeutics' gene therapy for blindness, a move that also boosts Swiss drugmaker Novartis that bought the rights to one of the world's costliest treatments outside the United States.
* UBIOME - APPOINTED JOSEPH JIMENEZ, FORMER CEO OF NOVARTIS, TO ITS BOARD Source text for Eikon: Further company coverage:
LONDON, Sept 19 Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people.
ZURICH Swiss drugmaker Novartis has revealed its employees only get a bonus if they meet or exceed expectations for ethical behavior as it seeks to address past shortcomings that have damaged its reputation.
ZURICH, Sept 17 Swiss drugmaker Novartis has revealed its employees only get a bonus if they meet or exceed expectations for ethical behaviour as it seeks to address past shortcomings that have damaged its reputation.
ZURICH/BERLIN, Sept 17 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 8,965 points on Monday, according to premarket indications by bank Julius Baer .
ZURICH The headquarters of Alcon, the eyecare unit of Novartis which will be spun off to shareholders in 2019, will move from the division's longtime corporate home in the Dallas suburbs to the Swiss city of Geneva, Novartis said in a statement on Tuesday.
|Johnson & Johnson (JNJ.N)||$140.47||-2.41|
|Pfizer Inc. (PFE.N)||$43.93||-0.13|
|Merck & Co., Inc. (MRK.N)||$70.78||-0.32|
|Roche Holding Ltd. (ROG.S)||CHF233.00||--|
|Roche Holding Ltd. (RO.S)||CHF234.00||--|
|Abbott Laboratories (ABT.N)||$71.44||+2.39|
|Sanofi SA (SASY.PA)||€73.86||--|
|AstraZeneca plc (AZN.L)||5,652.00||--|
|GlaxoSmithKline plc (GSK.L)||1,522.80||--|
|Eli Lilly And Co (LLY.N)||$105.59||-0.74|